Dr. Yu is the Chief Technology Officer at NChrovia. Before joining NChrovia, he spent 14 years leading complex manufacturing and R&D projects in the medical device industry. Dr. Yu played a pivotal role in advancing sensor technologies for two NICU in-line continuous blood monitoring systems. Additionally, he has 8 years of experience in leading biomedical sensor product development for in vitro diagnostic analyzers. Dr. Yu possesses extensive expertise in implantable and wearable biosensors, in vitro electrochemical sensors, microarrays, immunoassays and biomaterials. He has been awarded an NIH Small Business Innovation Research (SBIR) grant and contributed significantly to an R01 NIH research program. Dr. Yu has authored over 15 peer-reviewed publications and holds a US patent.

CEO/CTO

Dr. Bazhang Yu

Sohyun Kim is the director of product development of NChrovia. Currently, she is pursuing a Ph.D. degee in Biomedical Engineering at the University of Texas at Austin. Sohyun earned her master’s degree in Nano-Bioengineering and her bachelor’s degree in Optometry from Seoul National University of Science and Technology in Seoul, South Korea. Her diverse experience and academic background uniquely position her to drive NChrovia’s mission forward, bridging the gap between cutting-edge research and practical medical solutions.

Director of Product Development

Sohyun Kim

Dr. Tim Yeh is the co-Founder of NChrovia. Dr. Yeh discovered controlled activation and color-switching phenomena on DNA-templated silver nanoclusters. Based on these findings, he and co-workers invented NanoCluster Beacons, which won a 2011 R&D 100 Award and a 2013 Postdoctoral Publication Prize in Experimental Sciences at LANL.

Dr. Yeh joined the Biomedical Engineering Department at the University of Texas at Austin in 2012, where he is now a full professor. His research interests include nanobiosensor development, cancer biomarker detection, 3D molecular tracking and super-resolution imaging.

Dr. Yeh had more than 70 science publications and 6 US patents.

Co-Founder

Dr. Tim Yeh

Ms. Zeng brings over a decade of experience in business operations and sales strategy with Fortune 500 companies. In her most recent role at Dell Technologies, she supported North American sales organizations in generating billions in revenue. Prior to that, she held finance roles at Wells Fargo Bank and Anheuser-Busch. Her proven leadership skills foster effective communication across cross-functional teams, improve operational efficiency, and drive strategic business insights.

Chief Business Operation Officer

Jing Zeng

Dr. Ray Chen is an Endowed Chair Professor at The University of Texas at Austin and a recognized leader in photonics and optoelectronics. He is the Founder and Chairman of Omega Optics Inc., which has received over $20 million in research funding from government agencies and private industry.

Previously, Dr. Chen served as CTO and Chairman of Radiant Research, where he raised $18 million in venture funding to commercialize polymer-based photonic devices—technology later acquired by Finisar (NASDAQ:FNSR).

He has published over 1,000 papers, holds more than 80 U.S. patents, and has advised over 60 Ph.D. students. Dr. Chen is a Fellow of the National Academy of Inventors, IEEE, Optica, and SPIE, and has served as a consultant for numerous federal agencies and technology ventures.

Advisory Board Member

Dr. Ray T. Chen